Current use and outcomes of hematopoietic stem cell transplantation: Brazilian summary slides

Authors

  • Anderson João Simione Hospital Amaral Carvalho
  • Heliz Regina Alves das Neves Hospital de Clínicas – Universidade Federal do Paraná, Curitiba, PR
  • Cinthya Corrêa da Silva Hospital Israelita Albert Einstein, São Paulo, SP
  • Paula Moreira da Silva Sabaini Barretos Cancer Hospital, Barretos, SP
  • Bruna Letícia da Silva Santos Geraldo Associação da Medula Óssea, São Paulo - AMEO , SP
  • Marcelo C. Pasquini International Blood and Marrow Transplant Research (CIBMTR) and Medical College of Wisconsin, Milwaukee, WI, USA
  • Afonso Celso Vigorito Universidade Estadual de Campinas, Campinas, SP
  • Monique Ammi International Blood and Marrow Transplant Research (CIBMTR), Minneapolis, MN, USA
  • Vergilio Antonio Rensi Colturato Hospital Amaral Carvalho, Jaú, SP
  • Samir Kanaan Nabhan Hospital de Clínicas – Universidade Federal do Paraná, Curitiba, PR
  • Adriana Seber Associação da Medula Óssea, São Paulo - AMEO , SP / Grupo de Apoio ao Adolescente e à Criança com Câncer, São Paulo, SP / Hospital Samaritano, São Paulo, SP
  • Alexandre Silvério CEPON – Centro de Pesquisas Oncologicas, Florianópolis, SC
  • Maria Claudia Rodrigues Moreira Complexo Hospitalar de Niterói, Niterói, RJ
  • George Maurício Navarro Barros Barretos Cancer Hospital, Barretos, SP
  • Claudia Caceres Astigarraga Associação Hospitalar Moinhos de Ventos, Porto Alegre, RS
  • Liane Esteves Daudt Hospital de Clínicas de Porto Alegre, Porto Alegre, RS
  • Maria Cristina Martins de Almeida Macedo Hospital Leforte Liberdade SA, São Paulo, SP / Biosana’s, São Paulo, SP / IBCC – Instituto Brasileiro de Controle de Câncer, São Paulo, SP
  • Ricardo Chiattone Hospital Samaritano, São Paulo, SP
  • Yana Augusta Sarkis Novis Sociedade Beneficente de Senhoras Hospital Sírio Libanês, São Paulo, SP
  • Juliana Folloni Fernandes ITACI - Instituto da Criança do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, SP / Hospital Israelita Albert Einstein, São Paulo, SP
  • Volney Assis Lara Vilela Instituto de Cardiologia do Distrito Federal – Unidade Pietro Albuquerque, Brasília, DF
  • Decio Lerner Instituto Nacional do Câncer (INCA), Rio de Janeiro, RJ
  • Rodolfo Daniel de Almeida Soares Hospital Natal Center, Natal, RN
  • Phillip Scheinberg Real e Benemérita Sociedade de Beneficência Portuguesa de São Paulo, São Paulo, SP
  • Gustavo Machado Teixeira Hospital das Clínicas da Universidade Federal de Minas Gerais, Belo Horizonte, MG
  • Celso Arrais-Rodrigues Universidade Federal de São Paulo, São Paulo, SP
  • Marcos Paulo Colella Universidade Estadual de Campinas, Campinas, SP
  • Roberto Luiz da Silva IBCC – Instituto Brasileiro de Controle de Câncer, São Paulo, SP
  • Vaneuza Araújo Moreira Funke Hospital de Clínicas – Universidade Federal do Paraná, Curitiba, PR / Hospital Nossa Senhora das Graças – Instituto Pasquini, Curitiba, PR
  • Leonardo Javier Arcuri Hospital Israelita Albert Einstein, São Paulo, SP
  • Nelson Hamerschlak Hospital Israelita Albert Einstein, São Paulo, SP
  • Jayr Schmidt Filho A.C. Camargo Cancer Center, São Paulo, SP
  • Vinicius Campos de Molla Centro De Pesquisa Clínica Hospital 9 De Julho, São Paulo, SP
  • João Samuel de Holanda Farias Hospital Erasto Gaertner, Curitiba, PR
  • Ricardo Pasquini Hospital de Clínicas – Universidade Federal do Paraná, Curitiba, PR
  • Carmem Maria Sales Bonfim Hospital Pequeno Príncipe – Curitiba, PR
  • Abrahão Elias Hallack Neto Hospital Universitario da Universidade Federal de Juiz de Fora, Juiz de Fora, MG
  • Rodolfo Froes Calixto Real Hospital Português, Recife, PE
  • Luis Fernando Bouzas Hospital Unimed Volta Redonda, Rio de Janeiro, RJ
  • Fernando Barroso Duarte Hospital Universitário Walter Cantídio, Fortaleza, CE

DOI:

https://doi.org/10.46765/2675-374X.2022v3n2p171

Keywords:

Data Management, Hematopoietic Stem Cell Transplant, CIBMTR, SBTMO, DBtC, Brazilian Summary Slides.

Abstract

The first HSCT program in Latin America started in 1979 at the Federal University Hospital (Curitiba, Paraná). Over the years, the number of centers performing transplants in the country increased, generating the need to know the results of this modality of treatment. Understanding the HSCT scenario in Brazil is still challenging since not all Brazilian centers report data to the Center for International Blood and Marrow Research (CIBMTR). Although it has been improving over the last years, infrastructure and trained data managers are still lacking. The partnership between the Brazilian Cellular Therapy and Bone Marrow Transplant Society (SBTMO) and the CIBMTR, allowed the return of Brazilian data registered in the CIBMTR, through the Data Back to Center (DBtC), in a standardized and organized way. With this database it was possible to know the demographic data and the outcomes of transplants performed in Brazil. Between 2012 and 2021, complete information of 7,982 transplants were reported to the CIBMTR from 31 Brazilian transplant centers. The consolidation of the Hematopoietic Stem Cell Transplantation Brazilian Registry (HSCTBR) using CIBMTR infrastructure, allowed the Brazilian Summary slides development and update. Despite the difference in the number of cases and of follow-up time, the results in this study were similar to those presented in the US Summary Slides.

Author Biography

Maria Cristina Martins de Almeida Macedo, Hospital Leforte Liberdade SA, São Paulo, SP / Biosana’s, São Paulo, SP / IBCC – Instituto Brasileiro de Controle de Câncer, São Paulo, SP

 

 

Downloads

Published

10/03/2022

How to Cite

Simione, A. J., Neves, H. R. A. das, Silva, C. C. da, Sabaini, P. M. da S., Geraldo, B. L. da S. S., Pasquini, M., … Barroso Duarte, F. . (2022). Current use and outcomes of hematopoietic stem cell transplantation: Brazilian summary slides. JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY, 3(2), 171. https://doi.org/10.46765/2675-374X.2022v3n2p171

Issue

Vol. 3 No. 2 (2022): Journal of Bone Marrow Transplantation and Cellular Therapy

Section

Original article

License

Copyright (c) 2022 JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.